Illinois Municipal Retirement Fund’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Sell
25,006
-584
-2% -$7.87K ﹤0.01% 1092
2025
Q4
$287K Buy
25,590
+1,374
+6% +$15.7K ﹤0.01% 1127
2025
Q3
$280K Sell
24,216
-947
-4% -$11.1K ﹤0.01% 1159
2025
Q2
$308K Buy
25,163
+1,284
+5% +$16.1K ﹤0.01% 1192
2025
Q1
$342K Sell
23,879
-1,357
-5% -$21.2K 0.01% 1284
2024
Q4
$402K Buy
25,236
+748
+3% +$14.8K 0.01% 1262
2024
Q3
$588K Sell
24,488
-733
-3% -$16.8K 0.01% 1160
2024
Q2
$502K Sell
25,221
-564
-2% -$11K 0.01% 1194
2024
Q1
$513K Sell
25,785
-3,299
-11% -$63.8K 0.01% 1215
2023
Q4
$652K Buy
29,084
+1,262
+5% +$26.1K 0.01% 1120
2023
Q3
$563K Buy
+27,822
New +$631K 0.01% 1139

Other funds holding AVNS

Illinois Municipal Retirement Fund's AVNS Position: Q1 2026 in Review

Illinois Municipal Retirement Fund reduced its Avanos Medical (AVNS) stake by 2.3% in Q1 2026, selling an estimated $7.87K and leaving 25,006 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Illinois Municipal Retirement Fund first reported a position in AVNS in Q3 2023 and has held it in 11 quarters since. The position peaked at $652K in Q4 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Illinois Municipal Retirement Fund held 25,006 shares of Avanos Medical worth $350K as of Q1 2026.
  • Illinois Municipal Retirement Fund sold 584 Avanos Medical shares in Q1 2026, an estimated $7.87K.
  • Avanos Medical made up ﹤0.01% of Illinois Municipal Retirement Fund's portfolio in Q1 2026, its #1092 holding.
  • Illinois Municipal Retirement Fund first reported a position in Avanos Medical in Q3 2023 and has held it in 11 quarters since.
  • Illinois Municipal Retirement Fund's Avanos Medical position peaked at $652K in Q4 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q1 2026, filed 5 May 2026.